JNJ vs NVS

Johnson & Johnson against Novartis AG — live side-by-side technical comparison.

Prices as of 2026-11-11T15:52:45+00:00 UTC · updates daily

Who leads right now

JNJ leads 6 of the 7 windows we measure — over 1 month JNJ is +5.4% and NVS +10.8%; over year to date JNJ is +34.4% and NVS +15.6%. The JNJ/NVS price ratio stands at 1.7383, below its 50-day average of 1.7908, and above the 200-day average of 1.6371. A ratio above its own average means JNJ is gaining on NVS; on this reading the recent edge belongs to NVS.

JNJ/NVS over the last year

JNJ/NVS price ratio · dashed: its 50- and 200-day lines · ratio above its 50-day line = JNJ gaining on NVS
1.3951.5891.7821.976
Both rebased to 100 on 2025-11-11
100111.4129.5145.4JNJNVS
Ask
Compare JNJ and NVS: which has been stronger over the last year, and where does each stand against its 200-day average? Ask the analyst about this pair →

Performance side by side

JNJNVS
Price$276.96 $159.33
1 day -1.4%lead -2.4%
5 days +0.6%lead -3.4%
1 month +5.4% +10.8%lead
6 months +25.6%lead +9.7%
Year to date +34.4%lead +15.6%
1 year +42.9%lead +22.1%
2 years +78.6%lead +50.8%
52-week position 93% of range 76% of range
52-week range $193.07–$283.25 $123.24–$170.46
vs 50-day average above $266.48 above $149.21
vs 200-day average above $249.20 above $152.44
RSI (14) 58 56
Market cap$675.9B—
Analyst target $279.41 (-0.5%) —
Analysts22—
ConsensusBuy—
Next earnings Jan 26, 2027 Oct 27, 2026

Where each one stands

JNJ — Johnson & Johnson

JNJ trades at $276.96, above its 50-day average of $266.48, and above the 200-day at $249.20. It sits at 93% of its 52-week range ($193.07–$283.25); 14-day RSI is 58, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $281.54 (1.6% away) and the first support below is $275.53 (0.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

NVS — Novartis AG

NVS trades at $159.33, above its 50-day average of $149.21, and above the 200-day at $152.44. It sits at 76% of its 52-week range ($123.24–$170.46); 14-day RSI is 56, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $160.57 (0.8% away) and the first support below is $156.17 (2.0% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

Which one moves harder

JNJ is the more volatile of the two — an average session moves it 2.6% against 2.4% for NVS, so an identical position size carries roughly 1.1× the daily risk.

What would change the picture

The comparison turns on those levels: JNJ clearing $281.54 or losing $275.53; NVS clearing $160.57 or losing $156.17. Until one of them gives way, the relative reading above stands.

Questions people ask about JNJ vs NVS

Which is performing better right now, JNJ or NVS?
Over the past month JNJ is +5.4% and NVS is +10.8%, so NVS is ahead on that window. Year to date the figures are +34.4% for JNJ and +15.6% for NVS.
Which has done better over the last year, JNJ or NVS?
Over the last year JNJ is +42.9% and NVS is +22.1%, so JNJ is ahead on that window. Over two years it is +78.6% against +50.8%.
Is JNJ or NVS more volatile?
JNJ is the more volatile of the two — an average session moves it 2.6% against 2.4% for NVS, so an identical position size carries roughly 1.1× the daily risk.
What are the key levels for JNJ and NVS?
JNJ: resistance $281.54, support $275.53; NVS: resistance $160.57, support $156.17. Levels come from recent swing zones and round numbers, recomputed daily.
When do JNJ and NVS report next?
JNJ: Jan 26, 2027. NVS: Oct 27, 2026. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the JNJ/NVS ratio mean?
It is simply JNJ's price divided by NVS's — 1.7383 today. When the ratio rises, JNJ is outperforming; when it falls, NVS is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

JNJ →
Johnson & Johnson
Full technical brief: trend, levels, chart, news
NVS →
Novartis AG
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MerckLLY vs UNHLLY vs NVSAZN vs LLYLLY vs TMOAMGN vs LLY